FLUOROPHARMA MEDICAL, INC.

(FPMI)
Delayed OTC Markets  -  02:53 2022-07-28 pm EDT
0.003000 USD   -40.00%
06/23FluoroPharma Medical, Inc. Announces Executive Changes
CI
06/23FluoroPharma Medical, Inc. Appoints Frank I Igwealor as CFO
CI
06/23FLUOROPHARMA MEDICAL, INC. : Changes in Control or Registrant, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
AQ
SummaryQuotesChartsNewsCompany 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about FLUOROPHARMA MEDICAL, INC.
06/23FluoroPharma Medical, Inc. Announces Executive Changes
CI
06/23FluoroPharma Medical, Inc. Appoints Frank I Igwealor as CFO
CI
2018FluoroPharma Medical, Inc. Restructures CardioPET License With Massachusetts General Ho..
CI
2017FluoroPharma Medical, Inc. cancelled the acquisition of Ground Fluor Pharmaceuticals, I..
CI
2017FluoroPharma Medical, Inc. Auditor Raises 'Going Concern' Doubt
CI
2017FluoroPharma Medical, Inc. Announces Resignation of Lawrence Atinsky as Director and Me..
CI
2016FluoroPharma Medical, Inc. Borrows $50,000 in the Form of Promissory Note; Announces Bo..
CI
2016FluoroPharma Medical, Inc. announced that it has received $0.57 million in funding
CI
2016FLUOROPHARMA MEDICAL, INC. (OTCPK : FPMI) entered into a nonbinding letter of intent to ac..
CI
2016FluoroPharma Medical, Inc. Enters into Development and Commercialization Agreement with..
CI
2016Fluoropharma Medical Inc. Accepts First Comparative Data from it's Phase II Trial of Ca..
CI
2016FluoroPharma Medical, Inc. Auditor Raises 'Going Concern' Doubt
CI
2016FluoroPharma Medical, Inc. Announces Resignation of Andrew H. Sassine as Member of the ..
CI
2015FluoroPharma Medical, Inc. Announces Management Appointments
CI
2015FluoroPharma Medical, Inc. Announces Board Changes
CI
2015FluoroPharma Medical Inc Appoints Dr. Thomas H. Tulip as President
CI
2015FluoroPharma Medical, Inc. announced that it has received $2.78 million in funding
CI
2015FluoroPharma Medical, Inc. announced that it has received $0.195 million in funding.
CI
2015FluoroPharma Medical, Inc. Auditor Raises 'Going Concern' Doubt
CI
2014FluoroPharma Medical, Inc. Announces the Data from its Phase II Clinical Trial of 18-F ..
CI
2014FluoroPharma Medical, Inc. and The General Hospital Corporation Entered into Two Licens..
CI
2014Fluoropharma Medical, Inc. Presents Data from Phase II Clinical Trial of 18F FCPHA
CI
2014FluoroPharma Medical, Inc. Appoints H. William Strauss to Chair the Scientific Advisory..
CI
2014FluoroPharma Medical, Inc. Auditor Raises 'Going Concern' Doubt
CI
2014FluoroPharma Medical, Inc. Appoints Andrew H. Sassine to its Board of Directors, Effect..
CI
2014FluoroPharma Presents Data from Phase II Clinical Trial for (18) F-FCPHA
CI
2013FluoroPharma Medical, Inc. Names Edward L. Lyons, Jr. to Newly Created Position of Vice..
CI
2013FluoroPharma Medical, Inc. announced that it expects to receive $0.50 million in fundin..
CI
2013FluoroPharma Medical, Inc. Announces Internal Review of Imaging Data From Phase II Stud..
CI
2013FluoroPharma Medical, Inc. Appoints Joseph A. Pierro as Board of Director
CI
2013FluoroPharma Medical, Inc. Auditor Raises 'Going Concern' Doubt
CI
2013FluoroPharma Medical, Inc. Releases Initial Data from Phase II Study for CardioPET
CI
2013FluoroPharma Medical, Inc. Announces Phase II Study for BFPET (18)F-TPP
CI
2012FluoroPharma Medical, Inc. announced that it has received $1.54625 million in funding
CI
2012FluoroPharma Medical, Inc. Promotes Tamara Rhein to Chief Financial Officer
CI
2012FluoroPharma Medical, Inc. Announces Milestone for BFPET
CI
2012FluoroPharma Medical, Inc. Announces Executive Changes
CI
2012FluoroPharma Medical, Inc. Decides to Eliminate Dr. Elmaleh's Status as an Executive Of..
CI
2012FluoroPharma Medical, Inc. Grants Patent Rights for BFPET in Australia
CI
2012FluoroPharma Medical, Inc. Announces Phase II Study for CardioPET
CI